Claudio Ucciferri

University of Perugia

H指数:24

被引数:1,623

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimizing Cardiovascular Risk in PLWH: Real-World Efficacy and Lipid Kinetics of Fixed-Dose Combination Rosuvastatin Ezetimibe

优化HIV感染者心血管风险：瑞舒伐他汀联合依折麦布固定剂量组合的真实世界疗效及血脂动力学

Infectious Disease Reports

IF2.4

2026-10-180

Bictegravir/Tenofovir Alafenamide/Emtricitabine in Real-Life: A Multi-Year Experience

毕克替拉韦/阿洛夫酰胺替诺福韦/恩曲他滨在真实世界中的应用：一项多年经验研究

Journal of Clinical Medicine

IF2.9

2026-07-230

Reducing HPV Viral Burden in Men: A Synergistic Approach Using Pidotimod and Prophylactic Vaccination

减少男性HPV病毒负荷：一种使用匹多莫德和预防性疫苗接种的协同方法

Microorganisms

IF4.2

2026-06-120

OAAI

Dalbavancin in the Real-World Management of Gram-Positive Infections: A Systematic Review of Randomized and Observational Studies

达巴万星在革兰氏阳性菌感染真实世界管理中的应用：随机试验和观察性研究的系统综述

Microorganisms

IF4.2

2026-05-090

URO-RESIST: A Real-World Retrospective Study on Multidrug-Resistant Sepsis with Urinary Tract Infection, Clinical Predictors, Inflammatory Biomarkers, and Patient Outcomes

URO-RESIST：一项关于尿路感染合并多药耐药脓毒症的真实世界回顾性研究，涉及临床预测因子、炎症生物标志物及患者结局

Antibiotics 2025, Vol. 14, Page 1036

IF0

2025-10-160

OAAI

Efficacy and safety of deflazacort in diabetic subjects infected with SARS-CoV-2

deflazacort在感染SARS-CoV-2的糖尿病患者中的疗效与安全性

Multidisciplinary Respiratory Medicine

IF1.6

2025-10-031

OAAI

Gut Microbiota, Mild Cognitive Impairment and Dementia: A Systematic Review

肠道微生物群、轻度认知障碍和痴呆症：一项系统综述

Neurology International 2025, Vol. 17, Page 155

IF3

2025-09-300

OAAI

Cytokines assets in PLWH in two-drug dolutergravir based or three-drug antiretroviral regimen

BMC INFECTIOUS DISEASES

IF3

2024-07-031

OAAI

Antimicrobial resistance in intensive care patients hospitalized with SEPSIS: a comparison between the COVID-19 pandemic and pre-pandemic era

FRONTIERS IN MEDICINE

IF3

2024-05-150

OAAI

Ultrasound imaging of the axilla

INSIGHTS INTO IMAGING

IF4.5

2023-05-114

OAAI

Are monoclonal antibodies effective in patients with severe obesity in SARS-CoV-2 infected?

IMMUNITY INFLAMMATION AND DISEASE

IF2.7

2023-02-092

Predictive Value of Echocardiographic Pulmonary to Left Atrial Ratio for In-Hospital Death in Patients with COVID-19

DIAGNOSTICS

IF3.3

2023-01-071

OAAI

New Therapeutic Options in Mild Moderate COVID-19 Outpatients

MICROORGANISMS

IF4.2

2022-10-275

OAAI

Molnupiravir as an Early Treatment for COVID-19: A Real Life Study

PATHOGENS

IF3.3

2022-09-297

OAAI

Risk Factors Associated with Poor Outcome in Patients with Infective Endocarditis: An Italian Single-Center Experience

INFECTIOUS DISEASE REPORTS

IF2.4

2022-03-215

OAAI

Effects of Probiotic Mixture Supplementation on the Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine in People Living with HIV

NUTRIENTS

IF5

2021-12-090

OAAI

Parameters associated with diagnosis of COVID-19 in emergency department

IMMUNITY INFLAMMATION AND DISEASE

IF2.7

2021-05-078

Efficacy of canakinumab in mild or severe COVID-19 pneumonia

IMMUNITY INFLAMMATION AND DISEASE

IF2.7

2021-01-1946

OAAI

Circulating extracellular vesicles as new inflammation marker in HIV infection

AIDS

IF3.1

2020-12-0928

PRE

Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids

MICROORGANISMS

IF4.2

2020-08-3117

OAAI

Claudio Ucciferri

个人简介

教育背景

工作经历

荣誉奖项

研究方向